Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study

BACKGROUND: To advance the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), randomised controlled therapeutic studies with appropriate and sensitive outcomes are reuired. One candidate outcome is the 10-metre walk test (10MWT), a patient-centred, simple and functiona...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pilot Feasibility Stud
Autores principales: Martin, Fabiola, Inoue, Eisuke, Cortese, Irene C. M., de Almeida Kruschewsky, Ramon, Adonis, Adine, Grassi, Maria Fernanda Rios, Galvão-Castro, Bernardo, Jacobson, Steven, Yamano, Yoshihisa, Taylor, Graham P., Bland, Martin
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153909/
https://ncbi.nlm.nih.gov/pubmed/27965813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-015-0031-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares